Targeting the AXL signaling pathway in ovarian cancer

Por Huang, Ruby Yun-Ju, Antony, Jane, Tan, Tuan Zea, Tan, David Shao-Peng
Publicado no Mol Cell Oncol (2016)

Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients

Por Tan, Tuan Zea, Miow, Qing Hao, Miki, Yoshio, Noda, Tetsuo, Mori, Seiichi, Huang, Ruby Yun-Ju, Thiery, Jean Paul
Publicado no EMBO Mol Med (2014)

Rapid prototyping of concave microwells for the formation of 3D multicellular cancer aggregates for drug screening

Por Tu, Ting-Yuan, Wang, Zhe, Bai, Jing, Sun, Wei, Peng, Weng Kung, Huang, Ruby Yun-Ju, Thiery, Jean-Paul, Kamm, Roger D.
Publicado em 2013

CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype

Por Tan, Tuan Zea, Yang, He, Ye, Jieru, Low, Jeffrey, Choolani, Mahesh, Tan, David Shao Peng, Thiery, Jean-Paul, Huang, Ruby Yun-Ju
Publicado no Oncotarget (2015)

Histotype-specific copy-number alterations in ovarian cancer

Por Huang, Ruby YunJu, Chen, Geng Bo, Matsumura, Noriomi, Lai, Hung-Cheng, Mori, Seiichi, Li, Jingjing, Wong, Meng Kang, Konishi, Ikuo, Thiery, Jean-Paul, Goh, Liang
Publicado em 2012

Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)

Por Huang, Ruby Yun-Ju, Kuay, Kuee Theng, Tan, Tuan Zea, Asad, Mohammad, Tang, Hei Mui, Ng, Aloysius Hsien Chun, Ye, Jieru, Chung, Vin Yee, Thiery, Jean Paul
Publicado no Oncotarget (2015)

Screening therapeutic EMT blocking agents in a three-dimensional microenvironment

Por Aref, Amir R., Huang, Ruby Yun-Ju, Yu, Wei-miao, Chua, Kian-Ngiap, Sun, Wei, Tu, Ting-Yuan, Bai, Jing, Sim, Wen-Jing, Zervantonakis, Ioannis K, Thiery, Jean Paul, Kamm, Roger D.
Publicado em 2013

GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification

Por Chung, Vin Yee, Tan, Tuan Zea, Tan, Ming, Wong, Meng Kang, Kuay, Kuee Theng, Yang, Zhe, Ye, Jieru, Muller, Julius, Koh, Cheryl M., Guccione, Ernesto, Thiery, Jean Paul, Huang, Ruby Yun-Ju
Publicado no Sci Rep (2016)

A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets

Por Jia, Dongyu, Liu, Zhenqiu, Deng, Nan, Tan, Tuan Zea, Huang, Ruby Yun-Ju, Taylor-Harding, Barbie, Cheon, Dong-Joo, Lawrenson, Kate, Wiedemeyer, Wolf R., Walts, Ann E., Karlan, Beth Y., Orsulic, Sandra
Publicado no Cancer Lett (2016)

LNK (SH2B3): paradoxical effects in ovarian cancer

Por Ding, Ling-Wen, Sun, Qiao-Yang, Lin, De-Chen, Chien, Wenwen, Hattori, Norimichi, Dong, Xue-Ming, Gery, Sigal, Garg, Manoj, Doan, Ngan B., Said, Jonathan W., Xiao, Jin-Fen, Yang, Henry, Liu, Li-Zhen, Meng, Xuan, Huang, Ruby Yun-Ju, Tang, Kai, Koeffler, H Phillip
Publicado em 2014

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

Por Tan, Tuan Zea, Miow, Qing Hao, Huang, Ruby Yun-Ju, Wong, Meng Kang, Ye, Jieru, Lau, Jieying Amelia, Wu, Meng Chu, Bin Abdul Hadi, Luqman Hakim, Soong, Richie, Choolani, Mahesh, Davidson, Ben, Nesland, Jahn M, Wang, Ling-Zhi, Matsumura, Noriomi, Mandai, Masaki, Konishi, Ikuo, Goh, Boon-Cher, Chang, Jeffrey T, Thiery, Jean Paul, Mori, Seiichi
Publicado em 2013